Surrogate gene therapy for muscular dystrophy
An engineered truncated gene derived from the dystrophin-related protein (utrophin), prevents pathology without an immune response in an animal model of Duchenne muscular dystrophy (DMD) gene therapy.
Autors principals: | Davies, KE, Chamberlain, JS |
---|---|
Format: | Journal article |
Idioma: | English |
Publicat: |
Springer Nature
2019
|
Ítems similars
-
Therapeutic approaches to muscular dystrophy.
per: Goyenvalle, A, et al.
Publicat: (2011) -
The Pathogenesis and Therapy of Muscular Dystrophies
per: Guiraud, S, et al.
Publicat: (2015) -
Progress in therapy for Duchenne muscular dystrophy.
per: Fairclough, R, et al.
Publicat: (2011) -
Progress in therapy for Duchenne muscular dystrophy
per: Fairclough, R, et al.
Publicat: (2011) -
Utrophin in the therapy of Duchenne Muscular Dystrophy
per: Potter, A, et al.
Publicat: (2006)